Ellis M - Search Results

1

Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib.

Bagegni N, Thomas S, Liu N, Luo J, Hoog J, Northfelt DW, Goetz MP, Forero A, Bergqvist M, Karen J, Neumüller M, Suh EM, Guo Z, Vij K, Sanati S, Ellis M, Ma CX. Bagegni N, et al. Among authors: ellis m. Breast Cancer Res. 2017 Nov 21;19(1):123. doi: 10.1186/s13058-017-0913-7. Breast Cancer Res. 2017. PMID: 29162134 Free PMC article.

2

Letrozole inhibits tumor proliferation more effectively than tamoxifen independent of HER1/2 expression status.

Ellis MJ, Coop A, Singh B, Tao Y, Llombart-Cussac A, Jänicke F, Mauriac L, Quebe-Fehling E, Chaudri-Ross HA, Evans DB, Miller WR. Ellis MJ, et al. Cancer Res. 2003 Oct 1;63(19):6523-31. Cancer Res. 2003. PMID: 14559846 Clinical Trial.

3

Dramatic response of choroidal metastases from breast cancer to a combination of trastuzumab and vinorelbine.

Wong ZW, Phillips SJ, Ellis MJ. Wong ZW, et al. Breast J. 2004 Jan-Feb;10(1):54-6. doi: 10.1111/j.1524-4741.2004.09614.x. Breast J. 2004. PMID: 14717761

4

Treating breast cancer through novel inhibitors of the phosphatidylinositol 3'-kinase pathway.

Crowder RJ, Ellis MJ. Crowder RJ, et al. Breast Cancer Res. 2005;7(5):212-4. doi: 10.1186/bcr1307. Epub 2005 Aug 5. Breast Cancer Res. 2005. PMID: 16168140 Free PMC article.

5

The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancers.

Marcom PK, Isaacs C, Harris L, Wong ZW, Kommarreddy A, Novielli N, Mann G, Tao Y, Ellis MJ. Marcom PK, et al. Breast Cancer Res Treat. 2007 Mar;102(1):43-9. doi: 10.1007/s10549-006-9307-8. Epub 2006 Aug 8. Breast Cancer Res Treat. 2007. PMID: 16897431 Clinical Trial.

6

Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342.

Harris LN, Broadwater G, Lin NU, Miron A, Schnitt SJ, Cowan D, Lara J, Bleiweiss I, Berry D, Ellis M, Hayes DF, Winer EP, Dressler L. Harris LN, et al. Among authors: ellis m. Breast Cancer Res. 2006;8(6):R66. doi: 10.1186/bcr1622. Breast Cancer Res. 2006. PMID: 17129383 Free PMC article. Clinical Trial.

7

Neoadjuvant endocrine therapy for locally advanced breast cancer.

Ma CX, Ellis MJ. Ma CX, et al. Semin Oncol. 2006 Dec;33(6):650-6. doi: 10.1053/j.seminoncol.2006.08.013. Semin Oncol. 2006. PMID: 17145344 Review.

8

Letrozole in the neoadjuvant setting: the P024 trial.

Ellis MJ, Ma C. Ellis MJ, et al. Breast Cancer Res Treat. 2007;105 Suppl 1(Suppl 1):33-43. doi: 10.1007/s10549-007-9701-x. Epub 2007 Oct 3. Breast Cancer Res Treat. 2007. PMID: 17912634 Free PMC article. Clinical Trial.

9

Femara and the future: tailoring treatment and combination therapies with Femara.

Ellis M, Ma C. Ellis M, et al. Breast Cancer Res Treat. 2007;105 Suppl 1(Suppl 1):105-15. doi: 10.1007/s10549-007-9697-2. Epub 2007 Oct 3. Breast Cancer Res Treat. 2007. PMID: 17912640 Free PMC article. Review.

10

Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.

Ellis MJ, Tao Y, Luo J, A'Hern R, Evans DB, Bhatnagar AS, Chaudri Ross HA, von Kameke A, Miller WR, Smith I, Eiermann W, Dowsett M. Ellis MJ, et al. J Natl Cancer Inst. 2008 Oct 1;100(19):1380-8. doi: 10.1093/jnci/djn309. Epub 2008 Sep 23. J Natl Cancer Inst. 2008. PMID: 18812550 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,400 results

Search Page

Filters